HealthDaily digest, November 19, 2026
AI Accelerates Drug Discovery While Healthcare Data Access Evolves
This week brings major developments in AI-driven pharmaceutical research and electronic health records. Two major funding rounds underscore investor confidence in AI's potential to speed up drug development, while a leading healthcare software company moves to improve AI's access to patient data.
Merck Partners with Isomorphic Labs on AI-Powered Drug Discovery
Merck is collaborating with Isomorphic Labs, an AI drug discovery company founded on Nobel Prize-winning technology, to combine pharmaceutical expertise with advanced artificial intelligence for developing new treatments. The partnership aims to leverage AI capabilities to potentially accelerate drug development while reducing costs.
Why it matters: AI-driven drug discovery partnerships could accelerate the development of new therapeutics, potentially bringing treatments to patients faster and at lower development costs.
Sources: STAT News
London AI Startup Boltz Raises $110 Million for Drug Discovery Platform
Boltz, a London-based startup spun out of MIT that develops AI models to speed up pharmaceutical research, has secured $110 million in Series A funding led by Bessemer Venture Partners. The substantial investment reflects growing confidence among major investors that AI can significantly accelerate the expensive and lengthy drug development process.
Why it matters: Major funding for AI drug discovery signals investor confidence in AI's ability to speed up expensive and time-consuming drug development processes.
Sources: via Techmeme
Epic Systems Commits to Giving AI Tools Access to Patient Records
Epic Systems, the dominant provider of electronic health record software, has pledged to provide AI systems with access to patient health records while defending its broader competitive practices against regulatory scrutiny. The commitment addresses concerns about how artificial intelligence tools can better assist healthcare providers in their work.
Why it matters: Epic's pledge to open AI access to records could improve how AI tools assist healthcare providers, but the company's defense of its broader competitive tactics suggests ongoing tensions over data access and market dominance in EHR software.